The Department of Health and Human Services has defended cuts to vaccine research with statements that mislead on the safety of mRNA technology, despite an extensive history of testing. “After a ...
RNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the ...
When you buy through links on our articles, Future and its syndication partners may earn a commission. MRNA technology was thrust into the limelight during the COVID-19 pandemic, but had been in ...
Hosted on MSN
The disease-fighting promise of mRNA
In recent years, mRNA technology enabled the rapid development of vaccines to fight COVID-19, saving millions of lives. That same mRNA-powered approach to medicine—in which synthetic mRNA is ...
Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking ...
The path to therapeutic cancer vaccines is strewn with disappointment. In the 20-year history of clinical trials for vaccines that are designed to treat existing cancer by stimulating the immune ...
The Trump administration’s decision to terminate hundreds of millions of dollars to develop mRNA vaccines and treatments imperils the country’s ability to fight future pandemics and is built on false ...
US Health and Human Services is “winding down” its mRNA vaccine development and will instead fund other vaccine platforms through the Biomedical Advanced Research and Development Authority, the agency ...
(CNN) — Pharmaceutical rivals don’t often come to each other’s defense. But after the US Department of Health and Human Services terminated a contract with drugmaker Moderna to develop an mRNA bird ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results